Tuesday, Aug 11th
Last update08:13:34 AM GMT
Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
 Flanked by top health officials including Health Secretary Robert F. Kennedy Jr., President Trump unveiled a... |
 Respiratory therapist Marcy Freeman doesn't need a research study to confirm for her a return to... | ||
 "Do you even looksmaxx, bro?"If you've been online over the past year, odds are, you've come... |
 Cases of cyclosporiasis, a parasitic infection known for causing explosive diarrhea, have now reached 47 states... |
